463 related articles for article (PubMed ID: 33745432)
1. Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy.
Chalke SD; Kale PP
Curr Drug Targets; 2021; 22(16):1810-1824. PubMed ID: 33745432
[TBL] [Abstract][Full Text] [Related]
2. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
Narayanan SP; Shosha E; D Palani C
Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
[TBL] [Abstract][Full Text] [Related]
3. Diabetic retinopathy.
Wong TY; Cheung CM; Larsen M; Sharma S; Simó R
Nat Rev Dis Primers; 2016 Mar; 2():16012. PubMed ID: 27159554
[TBL] [Abstract][Full Text] [Related]
4. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy.
Rolev KD; Shu XS; Ying Y
Neuropharmacology; 2021 Apr; 187():108498. PubMed ID: 33582150
[TBL] [Abstract][Full Text] [Related]
5. Novel drugs and their targets in the potential treatment of diabetic retinopathy.
Nawaz MI; Abouammoh M; Khan HA; Alhomida AS; Alfaran MF; Ola MS
Med Sci Monit; 2013 Apr; 19():300-8. PubMed ID: 23619778
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
Kadłubowska J; Malaguarnera L; Wąż P; Zorena K
Curr Neuropharmacol; 2016; 14(8):831-839. PubMed ID: 27306035
[TBL] [Abstract][Full Text] [Related]
7. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease.
Szymanska M; Mahmood D; Yap TE; Cordeiro MF
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502350
[TBL] [Abstract][Full Text] [Related]
8. Diabetic Retinopathy: Pathophysiology and Treatments.
Wang W; Lo ACY
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
[TBL] [Abstract][Full Text] [Related]
9. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.
Rodríguez ML; Pérez S; Mena-Mollá S; Desco MC; Ortega ÁL
Oxid Med Cell Longev; 2019; 2019():4940825. PubMed ID: 31814880
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
Semeraro F; Morescalchi F; Cancarini A; Russo A; Rezzola S; Costagliola C
Diabetes Metab; 2019 Dec; 45(6):517-527. PubMed ID: 31005756
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy.
Bandello F; Toni D; Porta M; Varano M
Acta Diabetol; 2020 May; 57(5):513-526. PubMed ID: 31749046
[TBL] [Abstract][Full Text] [Related]
12. Nutraceuticals for the Treatment of Diabetic Retinopathy.
Rossino MG; Casini G
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987058
[TBL] [Abstract][Full Text] [Related]
13. Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies.
Whitehead M; Wickremasinghe S; Osborne A; Van Wijngaarden P; Martin KR
Expert Opin Biol Ther; 2018 Dec; 18(12):1257-1270. PubMed ID: 30408422
[TBL] [Abstract][Full Text] [Related]
14. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
Mudaliar S; Hupfeld C; Chao DL
J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.
Abcouwer SF; Gardner TW
Ann N Y Acad Sci; 2014 Apr; 1311():174-90. PubMed ID: 24673341
[TBL] [Abstract][Full Text] [Related]
16. Current and investigational drugs for the treatment of diabetic retinopathy.
Tolentino MS; Tolentino AJ; Tolentino MJ
Expert Opin Investig Drugs; 2016 Sep; 25(9):1011-22. PubMed ID: 27367620
[TBL] [Abstract][Full Text] [Related]
17. The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern.
Sun WJ; An XD; Zhang YH; Zhao XF; Sun YT; Yang CQ; Kang XM; Jiang LL; Ji HY; Lian FM
Front Endocrinol (Lausanne); 2023; 14():1270145. PubMed ID: 38027131
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic retinopathy: pathogenesis and therapeutic implications].
Pelikánová T
Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment and delivery system of diabetic retinopathy.
Wang Z; Zhang N; Lin P; Xing Y; Yang N
Front Endocrinol (Lausanne); 2024; 15():1347864. PubMed ID: 38425757
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of phytochemicals in diabetic retinopathy: experimental and clinical evidence.
Ojha S; Balaji V; Sadek B; Rajesh M
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2769-2783. PubMed ID: 28678306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
